Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. (Q45860403)
Jump to navigation
Jump to search
scientific article published on 6 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. |
scientific article published on 6 November 2011 |
Statements
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy (English)
Laura B Jardim
Roberto Giugliani
Cristina B O Netto
Giovana B Biancini
Camila S Vanzin
Daiane B Rodrigues
Marion Deon
Graziela S Ribas
Vanusa Manfredini
Carmen R Vargas
6 November 2011